Get Retatrutide Online in South Dakota | OmniRx Health

Medical Weight Loss Treatment in South Dakota

Retatrutide (LY3437943) is a 39-amino acid synthetic peptide and triple receptor agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Currently in Phase 3 clinical trials (TRIUMPH program), it produced 24.2% average weight loss at 48 weeks in Phase 2 data — the highest weight reduction observed in any peptide trial to date. Listed by OmniRx for research-use only (RUO).

Key Benefits

Triple receptor mechanism: GLP-1 + GIP + glucagon for amplified metabolic effect
Phase 2 data shows 24.2% average weight loss at 48 weeks (12mg dose)
~58% hepatic fat reduction in Phase 2 sub-group analyses
Elevated basal metabolic rate via glucagon receptor agonism
Research-grade purity ≥98% with full CoA, HPLC, and MS documentation

Who is a Good Candidate?

Intended for laboratory researchers and pre-clinical study investigators studying triple receptor agonism, obesity mechanisms, hepatic metabolism, or GLP/GIP/glucagon signaling pathways. Listed for research-use only (RUO) — not for human therapeutic use.

Available for research use

Serving South Dakota

From the Black Hills to the Badlands, Sioux Falls' growing metro to the ranches of the plains, South Dakota's natural beauty deserves healthcare to match. OmniRx Health serves the entire Mount Rushmore State—connecting residents across its vast landscape with expert medical care. When the nearest specialist is hours away across the prairie, our telehealth platform ensures you still have access to personalized, quality healthcare from the comfort of home.

Our providers are licensed by the South Dakota Board of Medical and Osteopathic Examiners for statewide telehealth services.

South Dakota pharmacies in Sioux Falls, Rapid City, and throughout the state provide prescription services with reliable delivery.

South Dakota's telehealth regulations support virtual care delivery while ensuring patient safety across its vast geography.

South Dakota insurers cover telehealth services, recognizing virtual care's essential role in serving the state's rural population.

Frequently Asked Questions

What is retatrutide and how does it work?: Retatrutide (CAS 2381089-83-2) is a 39-amino acid synthetic peptide that simultaneously activates GLP-1, GIP, and glucagon receptors. This triple agonism produces coordinated appetite suppression (GLP-1), amplified insulin and fat-cell metabolism (GIP), and increased hepatic glucose output and resting energy expenditure (glucagon). It is currently in Phase 3 clinical trials and is available for research-use only (RUO).
How does retatrutide compare to semaglutide and tirzepatide in research?: Phase 2 data (NEJM, 2023) showed retatrutide at 12mg produced 24.2% average weight loss at 48 weeks, outperforming semaglutide (~15% at 68 weeks) and tirzepatide (~22% at 72 weeks) in their respective trials. Retatrutide adds glucagon receptor agonism — absent in both comparators — which appears to drive additional metabolic rate elevation and hepatic fat clearance.
Is retatrutide available for human use?: No. Retatrutide has not received FDA approval for any human therapeutic use. It is currently in Phase 3 (TRIUMPH) clinical trials and is listed by OmniRx strictly as a research-use only (RUO) compound for laboratory and pre-clinical research applications.
Is telehealth legal in South Dakota?: Yes, South Dakota supports telehealth as essential for serving its dispersed population. Licensed providers can offer comprehensive virtual care including prescriptions.
Can Black Hills residents use telehealth?: Absolutely. Telehealth is ideal for Black Hills residents and tourists who may be far from major medical centers. Our platform brings care to wherever you are.
How does telehealth help reservation communities in SD?: Telehealth can complement existing healthcare services by providing additional specialty access for residents in remote reservation communities.